AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glibmor M 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Morgen Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glibmor M 1mg/500mg Tablet ER

Diabexe Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can lead to elevated blood sugar, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms – sweating, dizziness, headache, tremors – and know how to counteract it. Consistent mealtimes and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are vital. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glibmor M 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glibmor M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glibmor M 1mg/500mg Extended-Release Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer this medication with a meal.

Common Side effects of Glibmor M 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glibmor M 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glibmor M 1mg/500mg Extended-Release Tablets. Ingest the tablets whole; do not crush, chew, or break them. Administer this medication with food.

How Glibmor M 1mg/500mg Tablet ER works:

Glibmor M, a sustained-release tablet containing 1mg glimepiride and 500mg metformin, combines two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Glibmor M 1mg/500mg Extended-Release tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glibmor M 1mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Glibmor M tablets (1mg/500mg) are contraindicated during lactation due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glibmor M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glibmor M 1mg/500mg Extended-Release tablets. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glibmor M 1mg/500mg Extended-Release tablets cautiously. Dosage modification of Glibmor M 1mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised. For those with mild to moderate hepatic dysfunction, Glibmor M 1mg/500mg Extended-Release tablets are typically initiated at a reduced dosage; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Glibmor M 1mg/500mg Tablet ER :

Should you forget a Glibmor M 1mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glibmor M 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glibmor M 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication and keep it out of reach of children, pets, and others.
Glibmor M 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glibmor M 1mg/500mg Tablet ER and seek immediate medical attention.
Glibmor M 1mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glibmor M 1mg/500mg Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glibmor M 1mg/500mg Tablet ER can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glibmor M 1mg/500mg Tablet ER can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glibmor M 1mg/500mg ER tablets and alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glibmor M 1mg/500mg Table...
53
MRP 65
18% off